Samir Somaiya, Chairman and Managing Director, Godavari Biorefineries Limited

Godavari Biorefineries Limited has secured a product and process patent from the European Patent Office on a pharmaceutical composition that combines novel anti-cancer compounds with a solubilising agent, the company said.

The composition is designed to enhance the solubility and bioavailability of the active compounds, improving their therapeutic potential, the company said, adding that it has significant applications in treating cancers, including breast and prostate cancers, through oral administration. The patent adds to Godavari Biorefineries Limited’s oncology-focused intellectual property portfolio, it added.

Patent focuses on drug solubility and bioavailability

“In oncology research, identifying a promising compound is only one part of the challenge. How that compound is formulated can determine how effectively it can be developed for therapeutic use. Our research has focused on improving the solubility and bioavailability of these compounds, and the grant of this European patent is an important recognition of that work,” said Dr Sangeeta Srivastava, Executive Director, Godavari Biorefineries Limited.

Samir Somaiya, Chairman and Managing Director, Godavari Biorefineries Limited, said, as the company looked beyond its traditional businesses, “our investments in R&D are enabling us to build capabilities in areas where science and technology can address meaningful societal needs. This European patent is an important milestone in that journey, strengthening our intellectual property and opening possibilities for developing solutions with potential applications in healthcare.”

Somaiya Group’s bio-based business

Godavari Biorefineries is the flagship company of the Somaiya Group, one of the largest producers of ethanol and manufacturers of bio-based speciality chemicals in India.

Published on August 17, 2026